Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1224 | 1121 | 1328 | 1053 | 1642 | - |
Fund Return | 22.37% | 12.09% | 32.78% | 1.74% | 10.43% | - |
Place in category | 244 | 264 | 237 | 268 | 243 | - |
% in Category | 49 | 49 | 49 | 59 | 58 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bridge Builder Large Cap Growth | 25.37B | 23.68 | 6.99 | - | ||
Bridge Builder Large Cap Value | 21.46B | 21.10 | 11.76 | - | ||
Bridge Builder International Equity | 18.25B | 9.21 | 2.95 | - | ||
Bridge Builder Municipal Bond | 15.8B | 3.02 | 0.39 | - | ||
Bridge Builder Small/Mid Cap Value | 8.03B | 20.95 | 10.05 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.21B | 29.43 | 9.74 | 13.27 | ||
T. Rowe Price Mid-Cap Growth I | 12.89B | 15.57 | 3.54 | - | ||
Vanguard Mid-Cap Growth Index Admir | 13.35B | 23.87 | 3.42 | 11.06 | ||
T. Rowe Price Mid-Cap Growth | 12.08B | 15.44 | 3.40 | 10.90 | ||
T. Rowe Price New Horizons I | 9.96B | 13.92 | -5.33 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 1.25 | 619.20 | -0.74% | |
Tradeweb Markets | US8926721064 | 1.23 | 132.35 | -0.29% | |
Axon Enterprise | US05464C1018 | 1.13 | 627.00 | -0.74% | |
West Pharmaceutical Services | US9553061055 | 1.11 | 327.78 | -1.09% | |
Tyler Technologies | US9022521051 | 1.02 | 593.24 | -2.01% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review